[September 07, 2006] Teva begins sale of generic version of Zoloft (Sertraline) tablets, 25, 50 and 100 mg Tweet (Science Letter Via Thomson Dialog NewsEdge) Teva Pharmaceutical Industries Ltd. (TEVA) announced that it has begun the sale of its generic version of Pfizer's Zoloft (Sertraline) tablets, 25 mg, 50 mg, and 100 mg in the United States. As the first company to file an ANDA containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity. Teva's AB-rated Sertraline tablets are indicated for treatment of major depressive disorder. Annual brand product sales in the U.S. were approximately $3.1 billion for the 12 months ended June 2006, based on IMS data. Teva Pharmaceutical Industries is based in Israel. This article was prepared by Science Letter editors from staff and other reports. Copyright 2006, Science Letter via NewsRx.com. Copyright 2006 Science Letter via NewsRx.com [ Back To TMCnet.com's Homepage ]